Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Chubb
Federal Trade Commission
Farmers Insurance
AstraZeneca
Moodys
Medtronic
Argus Health
Cipla

Generated: October 19, 2018

DrugPatentWatch Database Preview

Ajanta Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA, and what generic and branded alternatives to AJANTA PHARMA drugs are available?

AJANTA PHARMA has twenty-seven approved drugs.

There is one tentative approval on AJANTA PHARMA drugs.

Summary for Ajanta Pharma
US Patents:0
Tradenames:23
Ingredients:22
NDAs:27
Patent Litigation for Ajanta Pharma: See patent lawsuits for Ajanta Pharma

Drugs and US Patents for Ajanta Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 207797-002 Sep 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 204320-003 May 30, 2017 DISCN No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd RANITIDINE HYDROCHLORIDE ranitidine hydrochloride CAPSULE;ORAL 209859-002 Sep 27, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 203328-001 Jul 31, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma LEVETIRACETAM levetiracetam TABLET;ORAL 201293-002 Jun 14, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Baxter
Daiichi Sankyo
Chubb
US Army
Boehringer Ingelheim
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.